Credit Suisse’s Lexicon Pharmaceuticals LXRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-145,746
| Closed | -$159K | – | 3100 |
|
|
2023
Q3 | $159K | Sell |
145,746
-5,694
| -4% | -$6.21K | ﹤0.01% | 3054 |
|
|
2023
Q2 | $347K | Buy |
151,440
+88,055
| +139% | +$202K | ﹤0.01% | 2943 |
|
|
2023
Q1 | $154K | Buy |
63,385
+20
| +0% | +$49 | ﹤0.01% | 3145 |
|
|
2022
Q4 | $121K | Buy |
63,365
+23,882
| +60% | +$45.6K | ﹤0.01% | 3283 |
|
|
2022
Q3 | $95K | Buy |
39,483
+508
| +1% | +$1.22K | ﹤0.01% | 3422 |
|
|
2022
Q2 | $72K | Sell |
38,975
-4,175
| -10% | -$7.71K | ﹤0.01% | 3567 |
|
|
2022
Q1 | $90K | Buy |
43,150
+406
| +0.9% | +$847 | ﹤0.01% | 3467 |
|
|
2021
Q4 | $168K | Sell |
42,744
-2,264
| -5% | -$8.9K | ﹤0.01% | 3479 |
|
|
2021
Q3 | $216K | Buy |
45,008
+13,446
| +43% | +$64.5K | ﹤0.01% | 3360 |
|
|
2021
Q2 | $144K | Buy |
31,562
+20,526
| +186% | +$93.6K | ﹤0.01% | 3482 |
|
|
2021
Q1 | $65K | Buy |
+11,036
| New | +$65K | ﹤0.01% | 3356 |
|
|
2020
Q3 | – | Sell |
-212,017
| Closed | -$423K | – | 3276 |
|
|
2020
Q2 | $423K | Buy |
212,017
+157,616
| +290% | +$314K | ﹤0.01% | 2785 |
|
|
2020
Q1 | $105K | Buy |
54,401
+22,199
| +69% | +$42.8K | ﹤0.01% | 3196 |
|
|
2019
Q4 | $134K | Buy |
32,202
+5,853
| +22% | +$24.4K | ﹤0.01% | 3379 |
|
|
2019
Q3 | $80K | Sell |
26,349
-940
| -3% | -$2.85K | ﹤0.01% | 3311 |
|
|
2019
Q2 | $171K | Sell |
27,289
-2,510
| -8% | -$15.7K | ﹤0.01% | 3238 |
|
|
2019
Q1 | $166K | Sell |
29,799
-3,733
| -11% | -$20.8K | ﹤0.01% | 3206 |
|
|
2018
Q4 | $223K | Sell |
33,532
-26,945
| -45% | -$179K | ﹤0.01% | 3103 |
|
|
2018
Q3 | $645K | Sell |
60,477
-65,086
| -52% | -$694K | ﹤0.01% | 2694 |
|
|
2018
Q2 | $1.51M | Buy |
125,563
+76,354
| +155% | +$916K | ﹤0.01% | 2297 |
|
|
2018
Q1 | $421K | Sell |
49,209
-1,265
| -3% | -$10.8K | ﹤0.01% | 3024 |
|
|
2017
Q4 | $498K | Sell |
50,474
-14,486
| -22% | -$143K | ﹤0.01% | 2952 |
|
|
2017
Q3 | $798K | Sell |
64,960
-2,527
| -4% | -$31K | ﹤0.01% | 2799 |
|
|
2017
Q2 | $1.11M | Sell |
67,487
-25,061
| -27% | -$412K | ﹤0.01% | 2280 |
|
|
2017
Q1 | $1.33M | Buy |
92,548
+19,978
| +28% | +$286K | ﹤0.01% | 2316 |
|
|
2016
Q4 | $1M | Buy |
72,570
+10,106
| +16% | +$140K | ﹤0.01% | 2691 |
|
|
2016
Q3 | $1.13M | Buy |
62,464
+1,638
| +3% | +$29.6K | ﹤0.01% | 2538 |
|
|
2016
Q2 | $873K | Sell |
60,826
-47,152
| -44% | -$677K | ﹤0.01% | 2767 |
|
|
2016
Q1 | $1.29M | Buy |
107,978
+78,416
| +265% | +$938K | ﹤0.01% | 2275 |
|
|
2015
Q4 | $393K | Sell |
29,562
-423
| -1% | -$5.62K | ﹤0.01% | 3316 |
|
|
2015
Q3 | $322K | Sell |
29,985
-92,095
| -75% | -$989K | ﹤0.01% | 3469 |
|
|
2015
Q2 | $983K | Buy |
122,080
+42,860
| +54% | +$345K | ﹤0.01% | 2949 |
|
|
2015
Q1 | $524K | Buy |
79,220
+25,854
| +48% | +$171K | ﹤0.01% | 3256 |
|
|
2014
Q4 | $340K | Buy |
53,366
+34,460
| +182% | +$220K | ﹤0.01% | 3608 |
|
|
2014
Q3 | $187K | Sell |
18,906
-12,256
| -39% | -$121K | ﹤0.01% | 3760 |
|
|
2014
Q2 | $350K | Sell |
31,162
-4,977
| -14% | -$55.9K | ﹤0.01% | 3599 |
|
|
2014
Q1 | $437K | Buy |
36,139
+8,402
| +30% | +$102K | ﹤0.01% | 3447 |
|
|
2013
Q4 | $350K | Sell |
27,737
-16,751
| -38% | -$211K | ﹤0.01% | 3543 |
|
|
2013
Q3 | $741K | Buy |
44,488
+6,644
| +18% | +$111K | ﹤0.01% | 2794 |
|
|
2013
Q2 | $575K | Buy |
+37,844
| New | +$575K | ﹤0.01% | 2832 |
|